Effectiveness of Jeryl Lynn-containing vaccine in Spanish children

Vaccine

Volumn 27, Issue 15, 2009, Pages 2089-2093

  Castilla, Jesús ^a,b   García Cenoz, Manuel ^a,b   Arriazu, Maite ^a,b   Fernández Alonso, Mirian ^c   Martínez Artola, Víctor ^d   Etxeberria, Jaione ^a,b   Irisarri, Fátima ^a,b   Barricarte, Aurelio ^a,b  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d Universidad Pública de Navarra   (Spain)

Author keywords

Case control study; Childhood; Effectiveness; Mumps; Vaccine; Waning of immunity

Indexed keywords

MEASLES MUMPS VACCINE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; EPIDEMIC; FEMALE; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUMPS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPAIN;

AGE FACTORS; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE NOTIFICATION; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; INFANT; LOGISTIC MODELS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; ODDS RATIO; RISK FACTORS; SPAIN; VACCINATION;

EID: 61549094032     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.001     Document Type: Article

References (26)

1. Peltola H., Davidkin I., Paunio M., Valle M., Leinikki P., and Heinonen O.P. Mumps and rubella eliminated from Finland. JAMA 284 (2000) 2643-2647
2. Centers for Disease Control and Prevention. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47(RR-8):1-57.
3. Savage E., Ramsay M., White J., Beard S., Lawson H., Hunjan R., et al. Mumps outbreaks across England and Wales in 2004: observational study. BMJ 330 (2005) 1119-1120
4. Sartorius B., Penttinen P., Nilsson J., Johansen K., Jonsson K., Arneborn M., et al. An outbreak of mumps in Sweden, February-April 2004. Euro Surveill 10 (2005) 191-193. http://www.eurosurveillance.org/em/v10n09/1009-221.asp
5. Dayan G.H., Quinlisk M.P., Parker A.A., Barskey A.E., Harris M.L., Schwartz J.M., et al. Recent resurgence of mumps in the United States. N Engl J Med 358 (2008) 1580-1589
6. Hviid A., Rubin S., and Mühlemann K. Mumps. Lancet 371 (2008) 932-944
7. Plotkin S.A. Mumps vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th edn. (2004), WB Saunders, Philadelphia 452
8. Vandermeulen C., Roelants M., Vermoere M., Roseeuw K., Goubau P., and Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure?. Vaccine 22 (2004) 2713-2716
9. Briss P.A., Fehrs L.J., Parker R.A., Wright P.F., Sannella E.C., Hutcheson R.H., et al. Sustained transmission of mumps in a highly vaccinated population: assessment of a primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 169 (1994) 77-82
10. Cohen C., White J.M., Savage E.J., Glynn J.R., Choi Y., Andrews N., et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 13 (2007) 12-17
11. Centro Nacional de Epidemiología. Situación de la parotiditis en España. Madrid: Instituto de Salud Carlos III, Junio; 2008. http://www.isciii.es/htdocs/centros/epidemiologia/epi_vacunables.jsp.
12. Sanz J.C., de Ory F., Fernández M., Herranz N., Méndez N., and Ramírez R. Evolución de los casos de parotiditis confirmados serológicamente en las Comunidad de Madrid durante un periodo de 7 años (2000-2006). Med Clin (Barc) 130 (2008) 292-294
13. Centers for Disease Control. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(RR-10):1-58.
14. Castilla J, García Cenoz M, Irisarri F, Núñez-Córdoba JM, Barricarte A. Mumps outbreak in Navarre region, Spain, 2006-2007. Euro Survell 2007;12(2):E070215.1. http://www.eurosurveillance.org/ViewArticle.aspx?PublicationType=W&Volume=12&Issue=7&OrderNumber=1.
15. Hersh B.S., Fine P.E., Kent W.K., Cochi S.L., Kahn L.H., Zell E.R., et al. Mumps outbreak in a highly vaccinated population. J Pediatr 119 (1991) 187-193
16. Harling R., White J.M., Ramsay M.E., Macsween K.F., and van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 23 (2005) 4070-4074
17. Gans H., DeHovitz R., Forghani B., Beeler J., Maldonado Y., and Arvin A.M. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 21 (2003) 3398-3405
18. Cheek J.E., Baron R., Atlas H., Wilson D.L., and Crider Jr. R.D. Mumps outbreak in a highly vaccinated school population. Evidence for large scale vaccination failure. Arch Pediatr Adolesc Med 149 (1995) 774-778
19. Davidkin I., Valle M., and Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up. Vaccine 13 (1995) 1617-1622
20. Miller E., Hill A., Morgan-Capner P., Forsey T., and Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 13 (1995) 799-802
21. Centres for Disease Control and Prevention. Guidelines for maintaining and managing the vaccine cold chain. MMWR Morb Mortal Wkly Rep 2003;52:1023-5.
22. Nojd J., Tecle T., Samuelsson A., and Orvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 19 (2001) 1727-1731
23. Fine P.E., and Zell E.R. Outbreaks in highly vaccinated populations: implications for studies of vaccine performance. Am J Epidemiol 139 (1994) 77-90
24. Rothman K.J., and Greenland S. Case-control studies. In: Rothman K.J., and Greenland S. (Eds). Modern epidemiology. 2nd edn. (1998), Lippincott-Raven Publishers, Philadelphia 93-114
25. Date A.A., Kyaw M.H., Rue A.M., Klahn J., Obrecht L., Krohn T., et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 197 (2008) 1662-1668
26. Dayan G.H., and Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?. Clin Infect Dis 47 (2008) 1458-1467